CCL20 and hepatocellular carcinoma: In hepatocellular cancer, miR-21 was predicted to regulate “immune response” by targeting CD69, STAT3, CCL20 and SMAD7, in which STAT3 and SMAD7 are important signaling molecules for immune response.